We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Biochemical Changes in Stored Donor Units Analyzed

By LabMedica International staff writers
Posted on 12 Jul 2018
Print article
Image: The HumaStar 80 clinical chemistry analyzer (Photo courtesy of Human Diagnostics).
Image: The HumaStar 80 clinical chemistry analyzer (Photo courtesy of Human Diagnostics).
Blood transfusion with allogeneic blood products is a common medical intervention to treat anemia or prepare patients for surgical procedures and generally, the blood units are secured and stored prior to expected transfusion.

During storage, several physical and biochemical changes take place in blood products that await transfusion, and the most affected product is whole blood. These changes known collectively as red cell storage lesion are progressive events that affect blood products stored for longer period than products stored for a short period.

Medical Laboratory Scientists at Mbarara University of Science and Technology (Mbarara, Uganda) recruited consecutively a total of 200 blood recipients were categorized into two study arms: group I of 100 received fresh blood and 100 in group II received old blood. A total of 2 mL of venous blood was collected from each participant in EDTA tubes before transfusion for pre-transfusion hemoglobin (Hb) estimation and after transfusion for post-transfusion Hb estimation. Each cross-matched unit was sampled to collect plasma for pH, lactate and potassium assays.

The Hb level was estimated using a Beckman Coulter Diagnostics full hemogram machine; donor lactate level was determined using HumaStar 80; and the potassium and pH in the donor units were determined by Human Diagnostics’ HumaLyte assays. Donor units were cultured in blood agar medium and incubated for 24 hours at 37 °C.

The team reported that the pH of the stored blood dropped from 7.4 to 7.2 in the first three days to ~7.0 by day 11 and to <7.0 by day 35. The mean rise in lactate level was 25 g/dL in blood stored for 0 to 11 days and 32.4 g/dL in blood stored for 21 to 35 days. The highest increase was encountered in blood stored beyond 28 days: 40–57 g/dL by 35 days. Potassium levels equally increased from ~4.6 mmol/L in the first five days of storage to ~14.3 mmol/L by 11 days. From the third week of blood storage and beyond, there was exponential increase in potassium levels, with the highest record in blood units stored from 30 to 35 days.

The authors concluded that whole blood stored for more than 14 days has reduced efficacy with increased markers of red cell storage lesion such as increased potassium level, lactate and fall in pH and these lesions increase the length of hospital stay. The study was published on June 25, 2018, in the Journal of Blood Medicine.

Related Links:
Mbarara University of Science and Technology

New
Gold Member
Human Chorionic Gonadotropin Test
hCG Quantitative - R012
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Chlamydia Trachomatis Assay
Chlamydia Trachomatis IgG
New
HbA1c Test
HbA1c Rapid Test

Print article

Channels

Clinical Chemistry

view channel
Image: The GlycoLocate platform uses multi-omics and advanced computational biology algorithms to diagnose early-stage cancers (Photo courtesy of AOA Dx)

AI-Powered Blood Test Accurately Detects Ovarian Cancer

Ovarian cancer ranks as the fifth leading cause of cancer-related deaths in women, largely due to late-stage diagnoses. Although over 90% of women exhibit symptoms in Stage I, only 20% are diagnosed in... Read more

Molecular Diagnostics

view channel
Image: Karius Focus BAL is designed to quickly identify the etiology of lung infections and improve diagnostic yield over standard of care testing (Photo courtesy of Karius)

Microbial Cell-Free DNA Test Accurately Identifies Pathogens Causing Pneumonia and Other Lung Infections

Bronchoalveolar lavage (BAL) is a commonly used procedure for diagnosing lung infections, especially in immunocompromised patients. However, standard tests often fail to pinpoint the exact pathogen, leading... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: The new algorithms can help predict which patients have undiagnosed cancer (Photo courtesy of Adobe Stock)

Advanced Predictive Algorithms Identify Patients Having Undiagnosed Cancer

Two newly developed advanced predictive algorithms leverage a person’s health conditions and basic blood test results to accurately predict the likelihood of having an undiagnosed cancer, including ch... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.